TACROLIMUS

TACROLIMUS was reported 159808 times

These side effects are most commonly reported by patients taking TACROLIMUS:

# Side effect Count
0 OFF LABEL USE 15788
1 DRUG INEFFECTIVE 10578
2 DRUG INTERACTION 6513
3 PRODUCT USE IN UNAPPROVED INDICATION 6480
4 ACUTE KIDNEY INJURY 6303
5 DIARRHOEA 6064
6 DEATH 5120
7 TRANSPLANT REJECTION 5112
8 PYREXIA 4949
9 CYTOMEGALOVIRUS INFECTION 4728
10 PNEUMONIA 4683
11 COVID-19 4007
12 TOXICITY TO VARIOUS AGENTS 3985
13 RENAL IMPAIRMENT 3760
14 SEPSIS 3633
15 NAUSEA 3375
16 CONDITION AGGRAVATED 3249
17 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 3126
18 VOMITING 3091
19 ANAEMIA 3076
20 BLOOD CREATININE INCREASED 2999
21 THROMBOTIC MICROANGIOPATHY 2989
22 RENAL FAILURE 2964
23 RESPIRATORY FAILURE 2914
24 SEPTIC SHOCK 2658
25 URINARY TRACT INFECTION 2651
26 HEADACHE 2645
27 NEUTROPENIA 2572
28 DYSPNOEA 2565
29 FATIGUE 2530
30 MULTIPLE ORGAN DYSFUNCTION SYNDROME 2451
31 INFECTION 2439
32 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 2437
33 HYPERTENSION 2427
34 KIDNEY TRANSPLANT REJECTION 2343
35 LEUKOPENIA 2267
36 RASH 2255
37 THROMBOCYTOPENIA 2231
38 PANCYTOPENIA 2114
39 PRURITUS 2108
40 ABDOMINAL PAIN 1978
41 CYTOMEGALOVIRUS VIRAEMIA 1933
42 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 1861
43 GRAFT VERSUS HOST DISEASE 1855
44 DRUG LEVEL INCREASED 1844
45 TREMOR 1795
46 ASTHENIA 1742
47 WEIGHT DECREASED 1735
48 PAIN 1720
49 EPSTEIN-BARR VIRUS INFECTION 1705
50 MALAISE 1599
51 BK VIRUS INFECTION 1584
52 ACUTE GRAFT VERSUS HOST DISEASE 1582
53 COUGH 1581
54 PRODUCT USE ISSUE 1579
55 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1573
56 DIABETES MELLITUS 1561
57 NEPHROPATHY TOXIC 1467
58 BRONCHOPULMONARY ASPERGILLOSIS 1420
59 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 1410
60 PLEURAL EFFUSION 1409
61 FEBRILE NEUTROPENIA 1396
62 HYPOTENSION 1395
63 ASPERGILLUS INFECTION 1392
64 COMPLICATIONS OF TRANSPLANTED KIDNEY 1377
65 CHRONIC KIDNEY DISEASE 1326
66 PNEUMOCYSTIS JIROVECII PNEUMONIA 1298
67 DECREASED APPETITE 1292
68 TRANSPLANT DYSFUNCTION 1279
69 ARTHRALGIA 1272
70 HOSPITALISATION 1251
71 HYPERKALAEMIA 1251
72 CYTOMEGALOVIRUS INFECTION REACTIVATION 1249
73 MATERNAL EXPOSURE DURING PREGNANCY 1242
74 DISEASE RECURRENCE 1240
75 DEHYDRATION 1217
76 CHRONIC GRAFT VERSUS HOST DISEASE 1206
77 DISEASE PROGRESSION 1197
78 ACUTE RESPIRATORY DISTRESS SYNDROME 1191
79 STAPHYLOCOCCAL INFECTION 1191
80 HAEMOGLOBIN DECREASED 1183
81 TREATMENT FAILURE 1155
82 DIZZINESS 1150
83 LIVER TRANSPLANT REJECTION 1108
84 FUNGAL INFECTION 1094
85 ALOPECIA 1093
86 PSEUDOMONAS INFECTION 1076
87 FOETAL EXPOSURE DURING PREGNANCY 1048
88 DERMATITIS ATOPIC 1039
89 KLEBSIELLA INFECTION 1034
90 ERYTHEMA 1029
91 INTERSTITIAL LUNG DISEASE 1026
92 EXPOSURE DURING PREGNANCY 1021
93 NOCARDIOSIS 1001
94 NEUROTOXICITY 994
95 ENTEROCOCCAL INFECTION 984
96 ESCHERICHIA INFECTION 983
97 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 977
98 ENCEPHALOPATHY 972
99 PROTEINURIA 972
100 CARDIAC ARREST 971
101 ASCITES 957
102 ADENOVIRUS INFECTION 956
103 CONFUSIONAL STATE 954
104 FALL 946
105 PLATELET COUNT DECREASED 946
106 INTENTIONAL PRODUCT USE ISSUE 942
107 DRUG RESISTANCE 941
108 BACTERAEMIA 939
109 PREMATURE BABY 923
110 OEDEMA PERIPHERAL 921
111 TRANSPLANT FAILURE 909
112 RENAL TUBULAR NECROSIS 902
113 KAPOSI^S SARCOMA 899
114 CANDIDA INFECTION 896
115 GASTROINTESTINAL DISORDER 893
116 DRUG INTOLERANCE 887
117 HERPES ZOSTER 871
118 WEIGHT INCREASED 869
119 RENAL FAILURE ACUTE 857
120 GASTROINTESTINAL HAEMORRHAGE 853
121 GENERAL PHYSICAL HEALTH DETERIORATION 852
122 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 841
123 END STAGE RENAL DISEASE 839
124 HEPATIC FAILURE 839
125 PRODUCT DOSE OMISSION ISSUE 836
126 RENAL DISORDER 831
127 ABDOMINAL PAIN UPPER 828
128 DRY SKIN 828
129 THERAPY NON-RESPONDER 828
130 DIFFUSE LARGE B-CELL LYMPHOMA 823
131 MUCORMYCOSIS 821
132 PAIN IN EXTREMITY 809
133 IMMUNOSUPPRESSANT DRUG LEVEL DECREASED 806
134 CARDIAC FAILURE 799
135 BACTERIAL INFECTION 795
136 TUBULOINTERSTITIAL NEPHRITIS 793
137 METABOLIC ACIDOSIS 787
138 SEIZURE 787
139 INFLUENZA 785
140 COLITIS 783
141 HYPERGLYCAEMIA 773
142 GRAFT VERSUS HOST DISEASE IN SKIN 764
143 INSOMNIA 763
144 OVERDOSE 763
145 CHILLS 742
146 COVID-19 PNEUMONIA 742
147 POLYOMAVIRUS VIRAEMIA 737
148 BACK PAIN 736
149 CHEST PAIN 736
150 ECZEMA 731
151 HYPONATRAEMIA 712
152 PREMATURE DELIVERY 711
153 WHITE BLOOD CELL COUNT DECREASED 711
154 BLOOD GLUCOSE INCREASED 707
155 ATRIAL FIBRILLATION 702
156 BLOOD PRESSURE INCREASED 701
157 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 701
158 HEPATIC FUNCTION ABNORMAL 701
159 TREATMENT NONCOMPLIANCE 701
160 TACHYCARDIA 693
161 MYALGIA 674
162 ALANINE AMINOTRANSFERASE INCREASED 671
163 VENOOCCLUSIVE LIVER DISEASE 671
164 PULMONARY EMBOLISM 668
165 ACUTE RESPIRATORY FAILURE 666
166 ANXIETY 648
167 SKIN EXFOLIATION 647
168 MULTI-ORGAN FAILURE 643
169 CONSTIPATION 640
170 CELLULITIS 637
171 LYMPHOPENIA 636
172 ABDOMINAL DISCOMFORT 627
173 HEART TRANSPLANT REJECTION 623
174 HYPOXIA 619
175 RESPIRATORY DISTRESS 618
176 DEPRESSION 612
177 MUCOSAL INFLAMMATION 611
178 PYELONEPHRITIS 608
179 RENAL TRANSPLANT FAILURE 607
180 MENTAL STATUS CHANGES 603
181 HEPATITIS C 600
182 HAEMORRHAGE 598
183 GAIT DISTURBANCE 597
184 LYMPHADENOPATHY 593
185 CEREBROVASCULAR ACCIDENT 591
186 SKIN LESION 587
187 SQUAMOUS CELL CARCINOMA OF SKIN 587
188 HEPATIC ENZYME INCREASED 586
189 NASOPHARYNGITIS 582
190 VIRAL INFECTION 579
191 MUSCULAR WEAKNESS 578
192 PERICARDIAL EFFUSION 576
193 CLOSTRIDIUM DIFFICILE INFECTION 569
194 ACNE 568
195 PNEUMONIA BACTERIAL 568
196 HYPOGAMMAGLOBULINAEMIA 567
197 DEEP VEIN THROMBOSIS 562
198 CLOSTRIDIUM DIFFICILE COLITIS 558
199 LOW BIRTH WEIGHT BABY 558
200 BONE MARROW FAILURE 554
201 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 554
202 DYSPHAGIA 551
203 CYTOMEGALOVIRUS COLITIS 548
204 DISSEMINATED INTRAVASCULAR COAGULATION 548
205 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 547
206 THERAPEUTIC RESPONSE DECREASED 547
207 DELAYED GRAFT FUNCTION 546
208 CHRONIC ALLOGRAFT NEPHROPATHY 544
209 PULMONARY OEDEMA 544
210 PARVOVIRUS B19 INFECTION 543
211 CYSTITIS HAEMORRHAGIC 541
212 ASPARTATE AMINOTRANSFERASE INCREASED 538
213 PERIPHERAL SWELLING 536
214 LIVER DISORDER 533
215 THROMBOSIS 528
216 OEDEMA 525
217 INCORRECT DOSE ADMINISTERED 523
218 SQUAMOUS CELL CARCINOMA 522
219 BRAIN ABSCESS 519
220 MYOCARDIAL INFARCTION 515
221 HERPES SIMPLEX 514
222 STOMATITIS 513
223 RENAL TRANSPLANT 512
224 EPSTEIN-BARR VIRAEMIA 509
225 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 507
226 COLITIS ULCERATIVE 506
227 CHOLESTASIS 505
228 PATHOGEN RESISTANCE 505
229 KIDNEY FIBROSIS 501
230 NEUROPATHY PERIPHERAL 501
231 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 499
232 HAEMATURIA 499
233 LIVER FUNCTION TEST ABNORMAL 498
234 SOMNOLENCE 496
235 UPPER RESPIRATORY TRACT INFECTION 496
236 DRUG LEVEL DECREASED 493
237 VISION BLURRED 492
238 INJECTION SITE PAIN 491
239 C-REACTIVE PROTEIN INCREASED 489
240 APLASIA PURE RED CELL 485
241 CRYPTOCOCCOSIS 485
242 INFLAMMATION 484
243 HYDRONEPHROSIS 481
244 SHOCK 479
245 ABDOMINAL DISTENSION 478
246 VISUAL IMPAIRMENT 477
247 OVARIAN CYST 472
248 PANCREATITIS ACUTE 472
249 CEREBRAL HAEMORRHAGE 465
250 PNEUMONIA CYTOMEGALOVIRAL 465
251 SINUSITIS 460
252 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 459
253 BLOOD UREA INCREASED 459
254 LUNG DISORDER 458
255 RESPIRATORY TRACT INFECTION 454
256 HYPOMAGNESAEMIA 453
257 DIABETIC KETOACIDOSIS 448
258 NEOPLASM MALIGNANT 446
259 NEPHROTIC SYNDROME 440
260 PSORIASIS 440
261 URTICARIA 440
262 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 439
263 UROSEPSIS 438
264 ABORTION SPONTANEOUS 437
265 PULMONARY NOCARDIOSIS 435
266 CONVULSION 434
267 PANCREATITIS 434
268 AGRANULOCYTOSIS 431
269 LOSS OF CONSCIOUSNESS 429
270 PNEUMATOSIS INTESTINALIS 428
271 TRANSAMINASES INCREASED 428
272 CYTOPENIA 427
273 MUSCLE SPASMS 426
274 PERITONITIS 426
275 THERAPY PARTIAL RESPONDER 426
276 MENINGITIS CRYPTOCOCCAL 422
277 MOUTH ULCERATION 421
278 GASTROENTERITIS 420
279 HEPATITIS E 419
280 SHOCK HAEMORRHAGIC 419
281 DEVICE RELATED INFECTION 418
282 COMA 417
283 BASAL CELL CARCINOMA 415
284 BLOOD BILIRUBIN INCREASED 415
285 STRONGYLOIDIASIS 407
286 VARICELLA ZOSTER VIRUS INFECTION 407
287 CYTOMEGALOVIRUS TEST POSITIVE 404
288 HYPERSENSITIVITY 404
289 MALACOPLAKIA 404
290 RHEUMATOID ARTHRITIS 402
291 PNEUMONIA FUNGAL 400
292 PARAESTHESIA 398
293 HISTOPLASMOSIS DISSEMINATED 396
294 FEELING ABNORMAL 395
295 SWELLING 394
296 CROHN^S DISEASE 393
297 HUMAN HERPESVIRUS 6 INFECTION 393
298 PULMONARY MASS 389
299 ENCEPHALITIS 387
300 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 387
301 HYPOAESTHESIA 386
302 RENAL TUBULAR INJURY 386
303 SPLENOMEGALY 385
304 DRUG HYPERSENSITIVITY 378
305 PNEUMONITIS 378
306 DISCOMFORT 377
307 JC VIRUS INFECTION 377
308 PHAEOHYPHOMYCOSIS 376
309 BRONCHITIS 370
310 CEREBRAL INFARCTION 369
311 MYELOSUPPRESSION 369
312 HAEMATOCHEZIA 368
313 LUNG TRANSPLANT REJECTION 368
314 ORGANISING PNEUMONIA 368
315 PRODUCTIVE COUGH 368
316 DRUG LEVEL ABOVE THERAPEUTIC 367
317 OSTEOMYELITIS 367
318 GASTRIC ULCER 361
319 LEUKOCYTOSIS 360
320 BLOOD LACTATE DEHYDROGENASE INCREASED 357
321 GRAFT LOSS 357
322 LYMPHOPROLIFERATIVE DISORDER 357
323 CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN 356
324 GASTROOESOPHAGEAL REFLUX DISEASE 354
325 ACUTE MYELOID LEUKAEMIA 353
326 HAEMOLYTIC ANAEMIA 353
327 HYPOKALAEMIA 352
328 INFECTION REACTIVATION 352
329 DELIRIUM 351
330 SKIN ULCER 351
331 BRAIN OEDEMA 350
332 CARDIAC FAILURE CONGESTIVE 350
333 ANURIA 349
334 DYSURIA 349
335 NO ADVERSE EVENT 349
336 HYPOALBUMINAEMIA 348
337 HAEMOLYTIC URAEMIC SYNDROME 346
338 MEMORY IMPAIRMENT 345
339 CHOLANGITIS 342
340 DRUG-INDUCED LIVER INJURY 340
341 DYSPEPSIA 339
342 SMOOTH MUSCLE CELL NEOPLASM 339
343 VIRAEMIA 338
344 OROPHARYNGEAL PAIN 337
345 ESCHERICHIA URINARY TRACT INFECTION 335
346 OSTEONECROSIS 335
347 FUNGAL SKIN INFECTION 333
348 ACTINIC KERATOSIS 332
349 HUMAN HERPESVIRUS 8 INFECTION 332
350 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 332
351 SLEEP DISORDER 332
352 DIALYSIS 330
353 HEART RATE INCREASED 330
354 NEPHROPATHY 330
355 HEPATOTOXICITY 329
356 JAUNDICE 329
357 STENOTROPHOMONAS INFECTION 329
358 BLOOD ALKALINE PHOSPHATASE INCREASED 328
359 LUNG INFECTION 328
360 DEPRESSED LEVEL OF CONSCIOUSNESS 327
361 PNEUMOTHORAX 327
362 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 325
363 DRY EYE 325
364 CATARACT 323
365 ELECTROLYTE IMBALANCE 323
366 HAEMATOMA 321
367 HAEMOPTYSIS 320
368 HYPERCALCAEMIA 320
369 BLOOD POTASSIUM INCREASED 318
370 COAGULOPATHY 317
371 FLUID RETENTION 317
372 IMMUNOSUPPRESSION 316
373 OXYGEN SATURATION DECREASED 316
374 WHITE BLOOD CELL COUNT INCREASED 316
375 ELECTROCARDIOGRAM QT PROLONGED 315
376 SYSTEMIC MYCOSIS 315
377 PNEUMONIA ASPIRATION 313
378 RENAL TUBULAR ATROPHY 313
379 HUMAN POLYOMAVIRUS INFECTION 312
380 OLIGURIA 311
381 OSTEOPOROSIS 310
382 STAPHYLOCOCCAL BACTERAEMIA 310
383 TRICHODYSPLASIA SPINULOSA 310
384 TUBERCULOSIS 309
385 ACUTE HEPATIC FAILURE 308
386 HEPATOCELLULAR CARCINOMA 307
387 RASH ERYTHEMATOUS 307
388 RENAL INJURY 307
389 SKIN CANCER 306
390 CARDIO-RESPIRATORY ARREST 305
391 BACTERIAL SEPSIS 303
392 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 302
393 CONTUSION 301
394 RESPIRATORY DISORDER 298
395 HAEMODIALYSIS 297
396 IMPAIRED HEALING 297
397 NERVOUS SYSTEM DISORDER 297
398 SURGERY 297
399 HEPATIC CIRRHOSIS 296
400 PALPITATIONS 293
401 EYE PAIN 292
402 ASTHMA 290
403 HAEMODYNAMIC INSTABILITY 289
404 LACTIC ACIDOSIS 289
405 SCEDOSPORIUM INFECTION 288
406 SYSTEMIC CANDIDA 288
407 ALTERED STATE OF CONSCIOUSNESS 287
408 BLOOD PRESSURE DECREASED 287
409 ANAPHYLACTIC REACTION 286
410 HEPATITIS 286
411 LIVER TRANSPLANT 286
412 CHEST DISCOMFORT 284
413 APHASIA 283
414 GLOMERULAR FILTRATION RATE DECREASED 283
415 HAEMATOCRIT DECREASED 283
416 INTESTINAL OBSTRUCTION 283
417 PULMONARY ALVEOLAR HAEMORRHAGE 283
418 CARDIAC DISORDER 282
419 GENERALISED TONIC-CLONIC SEIZURE 282
420 DYSPNOEA EXERTIONAL 280
421 BLINDNESS 278
422 BRADYCARDIA 277
423 URINE OUTPUT DECREASED 277
424 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 276
425 SYNCOPE 276
426 ENTEROBACTER INFECTION 275
427 HISTOPLASMOSIS 275
428 GASTRITIS 274
429 PHOTOSENSITIVITY REACTION 273
430 LETHARGY 272
431 HAEMORRHAGE INTRACRANIAL 271
432 ILLNESS 270
433 PULMONARY HYPERTENSION 270
434 RESPIRATORY SYNCYTIAL VIRUS INFECTION 270
435 THERAPY INTERRUPTED 270
436 APLASTIC ANAEMIA 269
437 LYMPHOCYTE COUNT DECREASED 269
438 LYMPHOMA 268
439 AGITATION 267
440 RHABDOMYOLYSIS 267
441 ATELECTASIS 266
442 HISTIOCYTOSIS HAEMATOPHAGIC 266
443 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 266
444 HYPERHIDROSIS 263
445 STAPHYLOCOCCAL SEPSIS 263
446 WEST NILE VIRAL INFECTION 262
447 ADVERSE DRUG REACTION 260
448 GAMMA-GLUTAMYLTRANSFERASE INCREASED 260
449 GLOMERULONEPHRITIS 260
450 HYPERBILIRUBINAEMIA 260
451 TOXOPLASMOSIS 260
452 NEPHROLITHIASIS 259
453 CYSTITIS 258
454 SWELLING FACE 258
455 MELAENA 257
456 SYSTEMIC LUPUS ERYTHEMATOSUS 257
457 LOWER RESPIRATORY TRACT INFECTION 256
458 EPISTAXIS 255
459 MALNUTRITION 255
460 PRE-ECLAMPSIA 255
461 SKIN INFECTION 254
462 DYSARTHRIA 253
463 ORAL HERPES 252
464 VIRAL HAEMORRHAGIC CYSTITIS 252
465 ABSCESS 251
466 DRUG EXPOSURE DURING PREGNANCY 250
467 ACUTE MYELOID LEUKAEMIA RECURRENT 249
468 EYE IRRITATION 249
469 POST PROCEDURAL COMPLICATION 248
470 AMNESIA 247
471 ESCHERICHIA BACTERAEMIA 247
472 FOOD ALLERGY 247
473 METASTASES TO LUNG 247
474 MYOPATHY 247
475 PULMONARY MUCORMYCOSIS 247
476 HEMIPARESIS 246
477 MYCOBACTERIAL INFECTION 246
478 PNEUMOCYSTIS JIROVECII INFECTION 245
479 WOUND INFECTION 244
480 ALTERNARIA INFECTION 243
481 HYPOGLYCAEMIA 243
482 PNEUMONIA KLEBSIELLA 243
483 RASH PRURITIC 243
484 RED BLOOD CELL COUNT DECREASED 243
485 CYTOMEGALOVIRUS CHORIORETINITIS 242
486 DISSEMINATED CRYPTOCOCCOSIS 242
487 FOETAL GROWTH RESTRICTION 242
488 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 242
489 RHINOVIRUS INFECTION 242
490 HYPOPHAGIA 241
491 LUNG INFILTRATION 237
492 VISUAL ACUITY REDUCED 237
493 DISORIENTATION 236
494 DIVERTICULITIS 236
495 STATUS EPILEPTICUS 236
496 VENOOCCLUSIVE DISEASE 236
497 DERMATITIS 235
498 ENDOPHTHALMITIS 235
499 EPILEPSY 235
500 HYPERLIPIDAEMIA 235
501 KIDNEY INFECTION 235
502 ACUTE MYOCARDIAL INFARCTION 234
503 DRUG LEVEL BELOW THERAPEUTIC 234
504 HAEMOLYSIS 234
505 HALLUCINATION 234
506 HEPATITIS B 234
507 RENAL TUBULAR ACIDOSIS 233
508 ENDOCARDITIS 232
509 INFUSION RELATED REACTION 232
510 NEUTROPHIL COUNT DECREASED 232
511 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 232
512 JOINT SWELLING 231
513 ORAL CANDIDIASIS 231
514 PNEUMONIA PSEUDOMONAL 231
515 RENAL FAILURE CHRONIC 231
516 DISSEMINATED TUBERCULOSIS 230
517 TOXIC ENCEPHALOPATHY 230
518 VERTIGO 230
519 BURNING SENSATION 229
520 AUTOIMMUNE HAEMOLYTIC ANAEMIA 228
521 FLUID OVERLOAD 228
522 INTENTIONAL PRODUCT MISUSE 228
523 MIGRAINE 227
524 SMALL INTESTINAL OBSTRUCTION 227
525 HYPOTHYROIDISM 226
526 SKIN FISSURES 226
527 ENTEROCOLITIS 225
528 OBLITERATIVE BRONCHIOLITIS 225
529 SUBARACHNOID HAEMORRHAGE 224
530 IGA NEPHROPATHY 223
531 ACUTE GRAFT VERSUS HOST DISEASE IN LIVER 222
532 ARTHRITIS 222
533 CARDIOGENIC SHOCK 222
534 CRYPTOSPORIDIOSIS INFECTION 222
535 MYELODYSPLASTIC SYNDROME 222
536 OESOPHAGITIS 221
537 POSTOPERATIVE WOUND INFECTION 221
538 NECROSIS 220
539 PULMONARY HAEMORRHAGE 220
540 RHINORRHOEA 220
541 GUILLAIN-BARRE SYNDROME 217
542 HYPERAMMONAEMIA 217
543 ARRHYTHMIA 216
544 BLASTOMYCOSIS 216
545 HYPOCALCAEMIA 216
546 OCULAR HYPERAEMIA 216
547 OESOPHAGEAL CANDIDIASIS 216
548 MALIGNANT NEOPLASM PROGRESSION 215
549 PSYCHOTIC DISORDER 215
550 ENTERITIS 214
551 ILEUS 214
552 MUSCULOSKELETAL STIFFNESS 214
553 PLASMA CELL MYELOMA 214
554 BLISTER 213
555 URINARY TRACT INFECTION BACTERIAL 213
556 URINARY RETENTION 212
557 LIVER ABSCESS 211
558 ACIDOSIS 210
559 LIVER INJURY 210
560 LYMPHOCELE 209
561 IRON DEFICIENCY ANAEMIA 208
562 DIPLOPIA 207
563 GASTROENTERITIS NOROVIRUS 207
564 HEPATITIS CHOLESTATIC 207
565 ATYPICAL HAEMOLYTIC URAEMIC SYNDROME 206
566 CORONARY ARTERY DISEASE 206
567 MYCOBACTERIUM AVIUM COMPLEX INFECTION 206
568 METASTASES TO LIVER 205
569 PRODUCT PRESCRIBING ISSUE 205
570 RASH MACULO-PAPULAR 205
571 DYSLIPIDAEMIA 204
572 LUNG NEOPLASM MALIGNANT 204
573 PREGNANCY 204
574 HEPATIC FIBROSIS 202
575 UNEVALUABLE EVENT 202
576 ARTERIOSCLEROSIS 201
577 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 201
578 HEPATIC STEATOSIS 200
579 LARGE INTESTINE PERFORATION 200
580 LUPUS NEPHRITIS 200
581 MYASTHENIA GRAVIS 200
582 NOROVIRUS INFECTION 200
583 PYELONEPHRITIS ACUTE 200
584 ENCEPHALITIS VIRAL 199
585 PNEUMONIA CRYPTOCOCCAL 199
586 RENAL GRAFT INFECTION 197
587 SKIN DISORDER 197
588 INFLAMMATORY BOWEL DISEASE 196
589 SKIN DISCOLOURATION 196
590 GRAFT VERSUS HOST DISEASE IN LIVER 195
591 INTESTINAL PERFORATION 195
592 LIVER FUNCTION TEST INCREASED 194
593 LUNG CONSOLIDATION 194
594 BALANCE DISORDER 193
595 OESOPHAGEAL ULCER 193
596 TACHYPNOEA 193
597 MEDICATION ERROR 191
598 SECONDARY IMMUNODEFICIENCY 191
599 BLOOD CREATININE ABNORMAL 190
600 CONJUNCTIVITIS 190
601 CYTOKINE RELEASE SYNDROME 190
602 ESCHERICHIA SEPSIS 190
603 KLEBSIELLA BACTERAEMIA 189
604 ACINETOBACTER INFECTION 188
605 COGNITIVE DISORDER 188
606 DRUG DOSE OMISSION 188
607 PULMONARY TUBERCULOSIS 188
608 CHOLELITHIASIS 187
609 EOSINOPHILIA 186
610 GENERALISED OEDEMA 186
611 NEPHROGENIC ANAEMIA 186
612 CORONAVIRUS INFECTION 185
613 INFLUENZA LIKE ILLNESS 185
614 LEUKOENCEPHALOPATHY 185
615 DRUG LEVEL FLUCTUATING 184
616 DRUG TOXICITY 184
617 DRY MOUTH 184
618 HYPERURICAEMIA 184
619 VACCINATION FAILURE 184
620 ANGIOEDEMA 183
621 DISSEMINATED MUCORMYCOSIS 183
622 LABORATORY TEST ABNORMAL 183
623 SKIN PAPILLOMA 182
624 HEPATIC NECROSIS 181
625 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 181
626 ALVEOLAR PROTEINOSIS 180
627 CENTRAL NERVOUS SYSTEM LESION 180
628 CEREBRAL TOXOPLASMOSIS 180
629 HYPERTRIGLYCERIDAEMIA 180
630 THROMBOTIC THROMBOCYTOPENIC PURPURA 180
631 ULCER 180
632 BLOOD CREATINE INCREASED 179
633 REBOUND EFFECT 179
634 ACCIDENTAL OVERDOSE 178
635 BLOOD MAGNESIUM DECREASED 178
636 CIRCULATORY COLLAPSE 178
637 MENTAL DISORDER 178
638 PNEUMOMEDIASTINUM 178
639 STRESS 178
640 TYPE 2 DIABETES MELLITUS 178
641 BONE PAIN 177
642 BRONCHIECTASIS 177
643 MYOSITIS 177
644 PULMONARY FIBROSIS 177
645 RASH MACULAR 177
646 MALIGNANT MELANOMA 176
647 SCLERODERMA 176
648 CARDIOMYOPATHY 175
649 HEPATIC ENCEPHALOPATHY 175
650 LEFT VENTRICULAR HYPERTROPHY 175
651 GOUT 174
652 BLOOD ALBUMIN DECREASED 173
653 BLOOD CHOLESTEROL INCREASED 173
654 DIARRHOEA HAEMORRHAGIC 173
655 EYE PRURITUS 173
656 ODYNOPHAGIA 173
657 PAPILLOMA VIRAL INFECTION 173
658 RENAL ARTERY STENOSIS 173
659 RENAL TUBULAR DISORDER 173
660 THERAPEUTIC RESPONSE SHORTENED 173
661 BOWEN^S DISEASE 172
662 SKIN HAEMORRHAGE 172
663 ADRENAL INSUFFICIENCY 171
664 HYPERVOLAEMIA 170
665 METASTASES TO LYMPH NODES 170
666 THERAPY CESSATION 170
667 HERPES VIRUS INFECTION 169
668 GRANULOMA 168
669 NEW ONSET DIABETES AFTER TRANSPLANTATION 168
670 SKIN MASS 168
671 INFECTIOUS PLEURAL EFFUSION 167
672 MENINGITIS 167
673 POST TRANSPLANT DISTAL LIMB SYNDROME 167
674 SKIN PLAQUE 167
675 HALLUCINATION, VISUAL 166
676 RENAL CELL CARCINOMA 166
677 EMOTIONAL DISTRESS 165
678 GRAFT VERSUS HOST DISEASE IN LUNG 165
679 HYPERPARATHYROIDISM SECONDARY 165
680 GINGIVAL HYPERTROPHY 163
681 HYPERTROPHIC CARDIOMYOPATHY 163
682 IMMUNODEFICIENCY 163
683 AUTOIMMUNE HEPATITIS 162
684 NASAL CONGESTION 162
685 PAPULE 162
686 FAILURE TO THRIVE 161
687 PRODUCT SUBSTITUTION ISSUE 161
688 SKIN NECROSIS 161
689 B-CELL LYMPHOMA 160
690 NIGHT SWEATS 160
691 SPEECH DISORDER 160
692 ADVERSE EVENT 159
693 HAEMORRHOIDS 159
694 HYPOVOLAEMIA 159
695 ABDOMINAL PAIN LOWER 158
696 ENGRAFTMENT SYNDROME 158
697 METASTASES TO BONE 158
698 SKIN BURNING SENSATION 158
699 WOUND DEHISCENCE 158
700 ASPERGILLOSIS 156
701 ATYPICAL MYCOBACTERIAL INFECTION 156
702 HYPOPHOSPHATAEMIA 156
703 URETERIC STENOSIS 156
704 BLOOD SODIUM DECREASED 155
705 MITRAL VALVE INCOMPETENCE 155
706 MYOCLONUS 155
707 ILL-DEFINED DISORDER 154
708 MYCOBACTERIUM ABSCESSUS INFECTION 154
709 NEUTROPHIL COUNT INCREASED 154
710 UNRESPONSIVE TO STIMULI 154
711 ISCHAEMIC STROKE 153
712 BLOOD TRIGLYCERIDES INCREASED 152
713 ENTEROCOCCAL BACTERAEMIA 152
714 GASTROINTESTINAL TOXICITY 152
715 INTRACRANIAL PRESSURE INCREASED 152
716 LOCALISED INFECTION 152
717 MASS 152
718 PERITONITIS BACTERIAL 152
719 COMPLICATIONS OF TRANSPLANTED LUNG 151
720 BRAIN HERNIATION 150
721 COMPLICATIONS OF TRANSPLANTED LIVER 150
722 LARGE INTESTINAL ULCER 150
723 PORTAL VEIN THROMBOSIS 150
724 PROTEIN URINE PRESENT 150
725 HEPATOMEGALY 149
726 INTERNATIONAL NORMALISED RATIO INCREASED 149
727 NEUROLOGICAL SYMPTOM 149
728 PANCREAS TRANSPLANT REJECTION 149
729 CARDIOMEGALY 148
730 MICROANGIOPATHIC HAEMOLYTIC ANAEMIA 148
731 MYOCARDITIS 148
732 PNEUMOCYSTIS JIROVECI PNEUMONIA 148
733 PNEUMONIA VIRAL 148
734 VASCULITIS 148
735 BILE DUCT STENOSIS 147
736 EYE DISORDER 147
737 IMMUNE SYSTEM DISORDER 147
738 MUSCULOSKELETAL PAIN 147
739 VENTRICULAR TACHYCARDIA 147
740 CEREBRAL ASPERGILLOSIS 146
741 CLOSTRIDIAL INFECTION 146
742 FLUSHING 146
743 MOBILITY DECREASED 146
744 POLLAKIURIA 146
745 STEROID DIABETES 146
746 DYSGEUSIA 145
747 NEPHROGENIC SYSTEMIC FIBROSIS 145
748 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 145
749 UPPER GASTROINTESTINAL HAEMORRHAGE 145
750 AZOTAEMIA 144
751 DEPRESSED MOOD 144
752 GASTROINTESTINAL INFECTION 144
753 GRAFT COMPLICATION 144
754 HAEMATOLOGICAL INFECTION 144
755 HEPATOCELLULAR INJURY 144
756 SUBCUTANEOUS ABSCESS 144
757 GASTROENTERITIS VIRAL 143
758 OPPORTUNISTIC INFECTION 143
759 CHRONIC MYELOID LEUKAEMIA 142
760 INFECTION IN AN IMMUNOCOMPROMISED HOST 142
761 OSMOTIC DEMYELINATION SYNDROME 142
762 CATATONIA 141
763 OESOPHAGEAL STENOSIS 141
764 UVEITIS 141
765 PRODUCT QUALITY ISSUE 140
766 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 140
767 ANGINA PECTORIS 139
768 BLOOD PRESSURE FLUCTUATION 139
769 FUNGAEMIA 139
770 HAEMATEMESIS 139
771 MYCOPLASMA INFECTION 139
772 PARAINFLUENZAE VIRUS INFECTION 139
773 RECTAL HAEMORRHAGE 139
774 CARDIAC FAILURE ACUTE 138
775 INTRAOCULAR PRESSURE INCREASED 138
776 PRODUCT PRESCRIBING ERROR 138
777 BLOOD PRESSURE SYSTOLIC INCREASED 137
778 GLOMERULOSCLEROSIS 137
779 IMMUNE THROMBOCYTOPENIA 137
780 POTENTIATING DRUG INTERACTION 137
781 TUMOUR LYSIS SYNDROME 137
782 ACCIDENTAL EXPOSURE TO PRODUCT 136
783 INJECTION SITE SWELLING 136
784 MICROSPORIDIA INFECTION 136
785 PORTAL HYPERTENSION 136
786 TRANSITIONAL CELL CARCINOMA 136
787 CENTRAL NERVOUS SYSTEM LYMPHOMA 135
788 NEUTROPENIC SEPSIS 135
789 OPTIC NEUROPATHY 135
790 VARICELLA 135
791 ATAXIA 134
792 BLOOD POTASSIUM DECREASED 134
793 ABDOMINAL ABSCESS 133
794 BODY TEMPERATURE INCREASED 133
795 CYTOMEGALOVIRUS ENTEROCOLITIS 133
796 HYDROCEPHALUS 133
797 SUICIDAL IDEATION 133
798 UREAPLASMA INFECTION 133
799 ARTHRITIS BACTERIAL 132
800 FEELING HOT 132
801 GLYCOSYLATED HAEMOGLOBIN INCREASED 132
802 SKIN IRRITATION 132
803 ABDOMINAL INFECTION 131
804 CYSTITIS VIRAL 131
805 ENTEROCOCCAL SEPSIS 131
806 GLOMERULONEPHRITIS MEMBRANOUS 131
807 PNEUMONIA STAPHYLOCOCCAL 131
808 PRESCRIBED UNDERDOSE 131
809 ANOREXIA 130
810 COMPLICATIONS OF TRANSPLANT SURGERY 130
811 DYSPHONIA 130
812 ENTEROVIRUS INFECTION 130
813 MYOCARDIAL ISCHAEMIA 130
814 NO THERAPEUTIC RESPONSE 130
815 RESPIRATORY ARREST 130
816 WHEEZING 130
817 CAESAREAN SECTION 129
818 INJECTION SITE ERYTHEMA 129
819 PERICARDITIS 129
820 INJURY 128
821 PNEUMOPERITONEUM 128
822 THERAPEUTIC PRODUCT EFFECT DECREASED 128
823 CUSHINGOID 127
824 EPSTEIN-BARR VIRUS TEST POSITIVE 127
825 FUSARIUM INFECTION 127
826 IRRITABILITY 127
827 METASTASIS 127
828 PULMONARY TOXICITY 127
829 AGGRESSION 126
830 CAT SCRATCH DISEASE 126
831 RESTLESSNESS 126
832 FLATULENCE 125
833 RASH PAPULAR 125
834 STREPTOCOCCAL INFECTION 125
835 CARDIAC TAMPONADE 124
836 CEREBRAL NOCARDIOSIS 124
837 CYTOMEGALOVIRUS ENTERITIS 124
838 HEPATOSPLENOMEGALY 124
839 KLEBSIELLA SEPSIS 124
840 LUNG TRANSPLANT 124
841 BLOOD CREATINE PHOSPHOKINASE INCREASED 123
842 CARDIOVASCULAR DISORDER 123
843 CHOLECYSTITIS 123
844 LIMB INJURY 123
845 POLYURIA 123
846 CACHEXIA 122
847 DUODENAL ULCER 122
848 CENTRAL NERVOUS SYSTEM INFECTION 121
849 CHRONIC GRAFT VERSUS HOST DISEASE IN LIVER 121
850 VISCERAL LEISHMANIASIS 121
851 ABORTION INDUCED 120
852 HYPERTRANSAMINASAEMIA 120
853 DISTURBANCE IN ATTENTION 119
854 HEPATIC CYTOLYSIS 119
855 PREMATURE LABOUR 119
856 DRUG ERUPTION 118
857 OSTEOARTHRITIS 118
858 PRODUCT DOSE OMISSION 118
859 PROSTATE CANCER 118
860 INTESTINAL ISCHAEMIA 117
861 OSTEOPENIA 117
862 RETINAL HAEMORRHAGE 117
863 SINUS TACHYCARDIA 117
864 TRANSIENT ISCHAEMIC ATTACK 117
865 GLOMERULONEPHRITIS MEMBRANOPROLIFERATIVE 116
866 HAEMATOTOXICITY 116
867 PHOTOPHOBIA 116
868 APHTHOUS ULCER 115
869 MONKEYPOX 115
870 NEPHRITIS 115
871 NORMOCYTIC ANAEMIA 115
872 SOFT TISSUE INFECTION 115
873 URINARY TRACT INFECTION ENTEROCOCCAL 115
874 BURKITT^S LYMPHOMA 114
875 CORYNEBACTERIUM INFECTION 114
876 DIABETES MELLITUS INADEQUATE CONTROL 114
877 HEPATITIS B REACTIVATION 114
878 IMPAIRED GASTRIC EMPTYING 114
879 PSEUDOMONAL SEPSIS 114
880 EMPYEMA 113
881 SUBDURAL HAEMATOMA 113
882 FISTULA 112
883 HEPATIC ARTERY THROMBOSIS 112
884 INFLAMMATORY MARKER INCREASED 112
885 PRODUCT DOSE OMISSION IN ERROR 112
886 SERUM FERRITIN INCREASED 112
887 SKIN HYPERPIGMENTATION 112
888 SPINAL COMPRESSION FRACTURE 112
889 TOXIC EPIDERMAL NECROLYSIS 112
890 URINARY INCONTINENCE 112
891 COLON CANCER 111
892 PARALYSIS 111
893 VASCULAR PSEUDOANEURYSM 111
894 DERMATOPHYTOSIS 110
895 FACIAL PARALYSIS 110
896 FEMUR FRACTURE 110
897 METABOLIC ENCEPHALOPATHY 110
898 PLEURISY 110
899 PULMONARY CONGESTION 110
900 ABSCESS LIMB 109
901 ANGIOPATHY 109
902 ANOGENITAL WARTS 109
903 CANDIDIASIS 109
904 DIFFUSE ALVEOLAR DAMAGE 109
905 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 109
906 INFECTIVE ANEURYSM 109
907 LUNG OPACITY 109
908 NORMOCHROMIC NORMOCYTIC ANAEMIA 109
909 SERUM SICKNESS 109
910 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOMA 108
911 NODULE 108
912 RALES 108
913 RENAL CYST 108
914 RHODOCOCCUS INFECTION 108
915 VENTRICULAR SEPTAL DEFECT 108
916 CYTOMEGALOVIRUS OESOPHAGITIS 107
917 ORAL DISORDER 107
918 PALLOR 107
919 WOUND 107
920 BLOOD GLUCOSE DECREASED 106
921 DYSKINESIA 106
922 EAR INFECTION 106
923 ILEAL ULCER 106
924 LUNG ABSCESS 106
925 NECK PAIN 106
926 STEM CELL TRANSPLANT 106
927 VENTRICULAR FIBRILLATION 106
928 BLOOD IMMUNOGLOBULIN G DECREASED 105
929 PHARYNGITIS 105
930 CHRONIC GRAFT VERSUS HOST DISEASE ORAL 104
931 FIBROSIS 104
932 HEART DISEASE CONGENITAL 104
933 OBSTRUCTIVE AIRWAYS DISORDER 104
934 SUPRAVENTRICULAR TACHYCARDIA 104
935 TYPE 1 DIABETES MELLITUS 104
936 DERMATOMYOSITIS 103
937 DISSEMINATED ASPERGILLOSIS 103
938 HERPES ZOSTER DISSEMINATED 103
939 HYPOVOLAEMIC SHOCK 103
940 PROPHYLAXIS AGAINST TRANSPLANT REJECTION 103
941 VIRAL LOAD INCREASED 103
942 CYTOMEGALOVIRUS GASTROINTESTINAL INFECTION 102
943 DONOR SPECIFIC ANTIBODY PRESENT 102
944 MOVEMENT DISORDER 102
945 NORMAL NEWBORN 102
946 PNEUMONIA PNEUMOCOCCAL 102
947 EYE SWELLING 101
948 HUMAN HERPESVIRUS 6 ENCEPHALITIS 101
949 LUNG ADENOCARCINOMA 101
950 NEUROENDOCRINE CARCINOMA OF THE SKIN 101
951 COMPLICATIONS OF TRANSPLANTED HEART 100
952 DUODENITIS 100
953 MYCOBACTERIUM HAEMOPHILUM INFECTION 100
954 PULSELESS ELECTRICAL ACTIVITY 100
955 TINNITUS 100
956 VASCULAR DEVICE INFECTION 100
957 ANGIOSARCOMA 99
958 APPENDICITIS 99
959 FRACTURE 99
960 IDIOPATHIC PNEUMONIA SYNDROME 99
961 ILEUS PARALYTIC 99
962 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 99
963 PROSTATITIS 99
964 SCAB 99
965 SUPERINFECTION BACTERIAL 99
966 ASPIRATION 98
967 GASTRIC DISORDER 98
968 GLUCOSE TOLERANCE IMPAIRED 98
969 LOCKED-IN SYNDROME 98
970 MALABSORPTION 98
971 NEOPLASM PROGRESSION 98
972 SCAR 98
973 TENDERNESS 98
974 TRANSPLANT 98
975 GESTATIONAL DIABETES 97
976 HUMAN EHRLICHIOSIS 97
977 HYPERCHOLESTEROLAEMIA 97
978 MUSCLE ATROPHY 97
979 RESTLESS LEGS SYNDROME 97
980 SLEEP APNOEA SYNDROME 97
981 THERAPEUTIC RESPONSE UNEXPECTED 97
982 ACANTHAMOEBA INFECTION 96
983 ARTHROPATHY 96
984 FUNGAL SEPSIS 96
985 GAIT INABILITY 96
986 NEURALGIA 96
987 NOSOCOMIAL INFECTION 96
988 PAIN OF SKIN 96
989 PROTEUS INFECTION 96
990 ROAD TRAFFIC ACCIDENT 96
991 TRANSPLANTATION ASSOCIATED FOOD ALLERGY 96
992 LIP SWELLING 95
993 POLYNEUROPATHY 95
994 POST PROCEDURAL HAEMORRHAGE 95
995 PRODUCT AVAILABILITY ISSUE 95
996 VISUAL FIELD DEFECT 95
997 BLOOD URIC ACID INCREASED 94
998 DRUG DISPENSING ERROR 94
999 GASTRIC CANCER 94